HDAC9 and atherosclerosis: Together with other studies, our data argue strongly for the existence of a pathological HDAC9/EndMT/atherosclerosis axis and suggest that targeting of HDAC9 may be beneficial for plaque stabilization or slowing the progression of atherosclerotic disease.